Optimal Approach to Diagnosis of Pulmonary Nodules (2024 AC LIVE)

Since completing fellowship, he has been in private practice with the Pinehurst Medical Clinic in Pinehurst, NC for over 16 years. He holds privileges at FirstHealth of the Carolinas, a 4-hospital system in central North Carolina. He serves as the Director of Thoracic Oncology and also the Director of the Chest Center of the Carolinas. He is active in multiple clinical trials as principal investigator in areas of advanced bronchoscopy, thoracic oncology, molecular pathology, COPD, asthma and pulmonary arterial hypertension. He has been an author on multiple studies in these areas. He is also one of the founding members and past president of the Society for Advanced Bronchoscopy. He has also served on the board of regents for the World Association for Bronchology and Interventional Pulmonology.

Dr. Pritchett has published extensively on navigation bronchoscopy platforms to assist with biopsy of peripheral nodules. Additionally, he pioneered the use of intraoperative cone-beam CT (CBCT) for use during biopsy of peripheral lung nodules. This technique has been shown to significantly increase the diagnostic yield of guided bronchoscopy and is now widely used throughout the world. This work with CBCT has led directly to being able to perform first-in-human trials with an FDA-approved device for bronchoscopic microwave ablation of peripheral lung tumors in 2018. Also, through his work with CBCT he identified the impact of atelectasis on guided bronchoscopy procedures and created an anesthesia protocol which has been published and is widely used today. He has also recently been the first in the U.S. to use the Intuitive Ion endoluminal robotic platform to perform bronchoscopy for peripheral lung lesions. Most recently he has become the first to enroll a patient in the AFFINITY trial using pulsed electric field treatment, in combination with CBCT and robotic bronchoscopy to treat metastatic lesions to the lung.